Scholarlink

Background <p>Cutaneous leishmaniasis (CL) is the most common clinical form of leishmaniasis and remains a major public health problem worldwide. In the Ethiopian setting, reports regarding the human immune response against CL infection are limited. Therefore, this study aimed to determine T lymphocyte subpopulations’ frequency, activation, and proliferation status from peripheral blood of LCL and DCL patients at the University of Gondar Hospital.</p> Methods <p>An institutional based cross-sectional study was conducted on 22 confirmed CL patients attending the <i>Leishmania</i> Research and Treatment Center (LRTC) of the University of Gondar Hospital from January to June 2017. As a control, 14 healthy participants were recruited from Voluntary Counseling and Testing (VCT) clinics of selected health centers. Blood samples were stained, and surface marker expression was evaluated by flow cytometry. Statistical analysis was performed using Kruskal-Wallis followed by Dunn’s multiple comparisons test and the differences were considered statistically significant when the P-values were &lt; 0.05. In this study, all the results are expressed as medians with inter-quartile range (IQR).</p> Results <p>Both DCL and LCL subjects showed an increased expression of CD38 and HLA-DR markers on T cell subsets compared to control groups. A significant reduction in the frequency of CD8<sup>+</sup> T cells was observed in the DCL as compared to the LCL patients (<i>P</i> = 0.04). The co-expression of CD38 and HLA-DR markers on CD4<sup>+</sup> and CD8<sup>+</sup> T cells was significantly higher among DCL patients when compared with health controls (HC) (<i>P</i> = 0.04) and (<i>P</i> = 0.01), respectively. In contrast, the proliferation marker Ki-67 expression by activated cells did not show significant differences between the CL cases and HC (<i>p</i> &gt; 0.05).</p> Conclusion <p>The expression levels of activation markers are associated with the LCL and DCL clinical forms of <i>L. aethiopica caused</i> CL. The presence of elevated levels of activated non-proliferating immune cells in DCL cases, as well as reduced numbers of CD8 T cells is consistent with a mechanism of T-cell activation followed by anergy and/or apoptosis.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Characterization of the activation status of T lymphocyte subpopulations in peripheral blood from localized and diffused cutaneous leishmaniasis patients at the University of Gondar Hospital, Ethiopia

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月16日

查看全文
  • Teshager Dubie,
  • Menberework Chanyalew,
  • Tekalign Deressa,
  • Abay Atnafu,
  • Demeke Geremew Debebe,
  • Tadelo Wondmagegn Melese,
  • Mohammed Adem,
  • Dareskedar Tsehay,
  • Melat Woldemariam,
  • Martha Zewdie,
  • Endalamaw Gadisa,
  • Rawleigh Howe

摘要

Background

Cutaneous leishmaniasis (CL) is the most common clinical form of leishmaniasis and remains a major public health problem worldwide. In the Ethiopian setting, reports regarding the human immune response against CL infection are limited. Therefore, this study aimed to determine T lymphocyte subpopulations’ frequency, activation, and proliferation status from peripheral blood of LCL and DCL patients at the University of Gondar Hospital.

Methods

An institutional based cross-sectional study was conducted on 22 confirmed CL patients attending the Leishmania Research and Treatment Center (LRTC) of the University of Gondar Hospital from January to June 2017. As a control, 14 healthy participants were recruited from Voluntary Counseling and Testing (VCT) clinics of selected health centers. Blood samples were stained, and surface marker expression was evaluated by flow cytometry. Statistical analysis was performed using Kruskal-Wallis followed by Dunn’s multiple comparisons test and the differences were considered statistically significant when the P-values were < 0.05. In this study, all the results are expressed as medians with inter-quartile range (IQR).

Results

Both DCL and LCL subjects showed an increased expression of CD38 and HLA-DR markers on T cell subsets compared to control groups. A significant reduction in the frequency of CD8+ T cells was observed in the DCL as compared to the LCL patients (P = 0.04). The co-expression of CD38 and HLA-DR markers on CD4+ and CD8+ T cells was significantly higher among DCL patients when compared with health controls (HC) (P = 0.04) and (P = 0.01), respectively. In contrast, the proliferation marker Ki-67 expression by activated cells did not show significant differences between the CL cases and HC (p > 0.05).

Conclusion

The expression levels of activation markers are associated with the LCL and DCL clinical forms of L. aethiopica caused CL. The presence of elevated levels of activated non-proliferating immune cells in DCL cases, as well as reduced numbers of CD8 T cells is consistent with a mechanism of T-cell activation followed by anergy and/or apoptosis.